Company Profile
Scarlet Therapeutics Limited
13536278•Private Limited With Share Capital
Get Full Access
28/07/2021
4 years
7
8
72110
low risk
Company Overview
Registration, classification & business activity
Scarlet Therapeutics Limited (13536278) is a private limited with share capital incorporated on 28/07/2021 (4 years old) and registered in bristol, BS20JZ. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Scarlet therapeutics is developing a unique platform that generates novel red blood cell-based therapeutics to potentially treat a wide range of diseases. initially targeted at the rare metabolic diseases, hyperammonemia and hyperoxaluria, this approach could also be used more broadly to target othe...
Financial Overview
£546.6K
£55.3K
£491.3K
£0
Key Metrics
8
Employees
7
Directors
10
Shareholders
Board of Directors
Innovate Grants
This company received a grant of £332036.02 for Univercell: An Engineered Red Blood Cell Line To Unlock A New, Universal Therapeutic Modality. The project started on 01/09/2023 and ended on 28/02/2025.
This company received a grant of £587680.0 for Bioengineered Reticulocytes Containing Metabolic Enzymes To Treat Hyperammonemia And Hyperoxaluria. The project started on 01/05/2024 and ended on 31/01/2026.
Import / Export
Risk Assessment
low risk
International Score
Future Factor
good
Performance Rating